Dr. Matthew Hudnall, MD

Dr. Hudnall practices at Permanente Medical Group Inc in Santa Clara, California.

Dr. Hudnall's NPI, 1750812608, was assigned on March 22, 2017. Dr. Hudnall graduated from UCSF School of Medicine in 2017. Dr. Hudnall holds California license A185710.

Dr. Hudnall's primary practice is Permanente Medical Group Inc, at 710 Lawrence Expy, Santa Clara, CA 95051 in Santa Clara County. The practice phone is (408) 851-1000.

Dr. Hudnall's primary practice is Permanente Medical Group Inc in Santa Clara, California. Dr. Hudnall is also affiliated with San Jose Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Hudnall to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hudnall practices. Vendor and product names are available with a free account.

Urology is Dr. Hudnall's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Hudnall's licenses on file in 2 states: California and Illinois.

Dmand AI lists bladder removal and kidney stone disease among the conditions Dr. Hudnall treats.

CMS data shows 228 Medicare services from Dr. Hudnall across 7 procedure codes in 2024, for 127 Medicare patients. Medicare paid $16,288 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Dr. Hudnall in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have cancer, and 75% have high blood pressure. 28% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hudnall's median patient age at 67, with 24% women.

In 2024, Dr. Hudnall wrote 131 Medicare Part D claims for 82 patients. 99% of them were for generic drugs. CMS names the drug for 73 of them, across 4 drugs with 11 or more claims each, at $362 in total drug cost. In 2023, CMS named 70 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Hudnall for performance year 2024, reported as part of a group. Dr. Hudnall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hudnall as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Hudnall, published from 2014 to 2023. 2022 was the busiest year, with 8. The most frequent topics are Semen, Semen Analysis and Testosterone. Dr. Hudnall has published most often in Urology. Dr. Hudnall's most frequent co-authors are Robert E. Brannigan, MD, Jeremy D. Lai, MD and Nelson E. Bennett, MD.

CMS Open Payments shows 36 general payments to Dr. Hudnall from 5 drug and device companies from 2018 to 2024. Travel and lodging make up the largest share, 57% of the total. Medtronic, Inc. paid the most, $2,705.

Dr. Hudnall graduated from UCSF School of Medicine in 2017.

Dr. Hudnall is in network with 12 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.